Andrew Bellinger - Dec 1, 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role: CSO & CMO
Signature: /s/ Andrew Ashe, as Attorney-in-Fact for Andrew Bellinger
Stock symbol: VERV
Transactions as of: Dec 1, 2022
Transactions value $: -$19,852
Form type: 4
Date filed: 12/2/2022, 04:00 PM
Previous filing: Nov 1, 2022
Next filing: Dec 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VERV	Common Stock	Sale	-$19.9K	-865	-11.54%	$22.95	6.63K	Dec 1, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired pursuant to the Verve Therapeutics, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on November 30, 2022 in a transaction exempt pursuant to Rule 16b-3(c). The shares were automatically sold through an automatic sale program in which the Reporting Person elected to participate on May 1, 2022. The sale does not represent a discretionary trade by the Reporting Person.

Content

Represents shares acquired pursuant to the Verve Therapeutics, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on November 30, 2022 in a transaction exempt pursuant to Rule 16b-3(c). The shares were automatically sold through an automatic sale program in which the Reporting Person elected to participate on May 1, 2022. The sale does not represent a discretionary trade by the Reporting Person.